UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Telesis Bio Inc (TBIO)

Telesis Bio Inc (TBIO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.3900 -0.0100 (-2.50%) 02/24/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.3900 unch (unch) 15:25 ET
Quote Overview for Mon, Feb 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.3750
Day High
0.4398
Open 0.4398
Previous Close 0.4000 0.4000
Volume 900 900
Avg Vol 4,065 4,065
Stochastic %K 58.82% 58.82%
Weighted Alpha -87.29 -87.29
5-Day Change +0.0200 (+5.41%) +0.0200 (+5.41%)
52-Week Range 0.2500 - 13.6620 0.2500 - 13.6620
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 702
  • Shares Outstanding, K 1,801
  • Annual Sales, $ 27,510 K
  • Annual Income, $ -47,720 K
  • EBIT $ -32 M
  • EBITDA $ -15 M
  • 60-Month Beta 1.64
  • Price/Sales 12.77
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -20.52
  • Most Recent Earnings $-3.83 on 11/07/24
  • Next Earnings Date 03/27/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2740 +42.34%
on 01/27/25
Period Open: 0.4000
0.4500 -13.33%
on 02/13/25
-0.0100 (-2.50%)
since 01/24/25
3-Month
0.2500 +56.00%
on 01/08/25
Period Open: 0.9100
0.9100 -57.14%
on 12/02/24
-0.5200 (-57.14%)
since 11/22/24
52-Week
0.2500 +56.00%
on 01/08/25
Period Open: 14.0400
13.6620 -97.15%
on 02/26/24
-13.6500 (-97.22%)
since 02/23/24

Most Recent Stories

More News
Telesis Bio: Q3 Earnings Snapshot

Telesis Bio: Q3 Earnings Snapshot

TBIO : 0.3900 (-2.50%)
Telesis Bio: Q2 Earnings Snapshot

Telesis Bio: Q2 Earnings Snapshot

TBIO : 0.3900 (-2.50%)
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

LEXINGTON, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines...

TBIO : 0.3900 (-2.50%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates TGRF, SIC, SAFM, TBIO; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / August 26, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: TGR Financial, Inc. (OTCQX:TGRF) concerning potential...

TGRF : 15.5500 (+1.83%)
SAFM : 204.00 (-2.51%)
TBIO : 0.3900 (-2.50%)
SIC : 14.49 (+0.07%)
INVESTIGATION: Halper Sadeh LLP Investigates CMO, TBIO, SIC, SAFM; Shareholders are Encouraged to Contact the Firm

NEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CMO : 6.50 (+2.52%)
TBIO : 0.3900 (-2.50%)
SIC : 14.49 (+0.07%)
SAFM : 204.00 (-2.51%)
INVESTIGATION: Halper Sadeh LLP Investigates SAFM, SBKK, SQ, TBIO; Shareholders are Encouraged to Contact the Firm

NEW YORK, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SAFM : 204.00 (-2.51%)
SBKK : 18.5800 (+1.03%)
SQ : 86.96 (+0.67%)
TBIO : 0.3900 (-2.50%)
Translate Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update

-- Entered into a definitive agreement under which Sanofi will acquire, subject to customary  conditions to closing, all outstanding shares of Translate Bio with a goal of advancing deployment of mRNA...

TBIO : 0.3900 (-2.50%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates SQ, TBIO, OSBC, IKNX; Shareholders are Encouraged to Contact the Firm

NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SQ : 86.96 (+0.67%)
TBIO : 0.3900 (-2.50%)
OSBC : 18.08 (-1.36%)
IKNX : 33.90 (-0.29%)
Lifshitz Law Firm, P.C. Announces Investigation of HFC, OSBC, RYFL and TBIO

NEW YORK, Aug. 04, 2021 (GLOBE NEWSWIRE) --

HFC : 36.39 (+1.99%)
OSBC : 18.08 (-1.36%)
RYFL : 20.2500 (-1.22%)
TBIO : 0.3900 (-2.50%)
TRANSLATE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Translate Bio - TBIO

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Translate Bio (NasdaqGS: TBIO) to Sanofi (NasdaqGS:...

TBIO : 0.3900 (-2.50%)
SNY : 53.75 (-1.30%)

Business Summary

Telesis Bio is an automated multi-omic and synthetic biology solutions company. Its BioXp(R) system consolidates, automates and optimizes the entire synthesis, cloning and amplification workflow. Telesis Bio, formerly known as Codex DNA Inc., is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 0.4930
2nd Resistance Point 0.4664
1st Resistance Point 0.4282
Last Price 0.3900
1st Support Level 0.3634
2nd Support Level 0.3368
3rd Support Level 0.2986

See More

52-Week High 13.6620
Fibonacci 61.8% 8.5386
Fibonacci 50% 6.9560
Fibonacci 38.2% 5.3734
Last Price 0.3900
52-Week Low 0.2500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements